|
CMTM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.66250379918642E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37740002631648E-09 |
| Normal-vs-Stage2 |
1.202800E-01 |
| Normal-vs-Stage3 |
9.95340000420342E-08 |
| Normal-vs-Stage4 |
1.636310E-03 |
| Stage1-vs-Stage2 |
1.532440E-02 |
| Stage1-vs-Stage3 |
1.983170E-01 |
| Stage1-vs-Stage4 |
9.104300E-02 |
| Stage2-vs-Stage3 |
1.276110E-03 |
| Stage2-vs-Stage4 |
1.025700E-02 |
| Stage3-vs-Stage4 |
2.354800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1433999020104E-10 |
| Normal-vs-AfricanAmerican |
1.038160E-04 |
| Normal-vs-Asian |
2.752800E-04 |
| Caucasian-vs-AfricanAmerican |
2.330400E-01 |
| Caucasian-vs-Asian |
9.329400E-01 |
| AfricanAmerican-vs-Asian |
2.624000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20000000003451E-06 |
| Normal-vs-Female |
3.2671998440037E-10 |
| Male-vs-Female |
5.728000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.19840001758342E-09 |
| Normal-vs-Age(41-60Yrs) |
1.1492000018265E-08 |
| Normal-vs-Age(61-80Yrs) |
3.604000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.284160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.401000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.100000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.558000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.916400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.490800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.997600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.643000E-01 |
| Classical-VS-Follicular |
5.77649039712469E-13 |
| Classical-VS-Other |
3.066800E-01 |
| Classical-VS-Normal |
9.29256671611256E-14 |
| Tall-VS-Follicular |
1.88970000003508E-06 |
| Tall-VS-Other |
7.951700E-02 |
| Tall-VS-Normal |
2.09029999997945E-06 |
| Follicular-VS-Other |
2.409800E-01 |
| Follicular-VS-Normal |
8.936600E-01 |
| Other-VS-Normal |
3.366800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30799999999931E-05 |
| Normal-vs-N1 |
3.022100E-03 |
| N0-vs-N1 |
6.197500E-02 |
|
|
